1. The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection.
- Author
-
Sone, Saburo, Izawa, Akiko, Narumi, Hideki, Kajita, Akemi, Tanabe, Junichi, and Taguchi, Fumihiro
- Subjects
VIRAL hepatitis ,INTERFERONS ,RIBAVIRIN ,DRUG efficacy ,HEPATITIS treatment ,LABORATORY mice - Abstract
Aim: To determine the differences in efficacy between therapy using IFN-β and ribavirin, and using IFN-α and ribavirin. Methods: We studied the effect of combination therapy consisting of IFN-β and ribavirin on mouse hepatitis virus (MHV) infection in mice. Results: Combination treatment of ribavirin and IFN-α was more effective than IFN-α mono-treatment in the MHV-mouse system, and combination treatment with ribavirin and IFN-β was more effective than IFN-β mono-treatment in the MHV-mouse system. Furthermore, administering IFN-β once or twice one day before combination treatment using ribavirin and IFN-α was more effective than administering IFN-α once or twice one day before the combination treatment using ribavirin and IFN-α. Conclusion: These data indicate that this MHV-infection system is a good animal model to assess anti-HCV activity for therapy using IFN and ribavirin, and suggest that administering IFN-β before the start of combination therapy with ribavirin and IFN-α promotes the therapeutic effects of combination treatment with ribavirin and IFN-α ?in chronic hepatitis C patients. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF